Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Okkerse

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|May 12, 2016
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task BatteryJustin L Hay, Pieter Okkerse, Guido van Amerongen, et al.
British Journal of Clinical Pharmacology|December 18, 2016
Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic propertiesPieter Okkerse, Justin L Hay, Elske Sitsen, et al.
Anesthesiology|September 16, 2014
Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteersMargot Roozekrans, Rutger van der Schrier, Pieter Okkerse, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy SubjectsMichiel J van Esdonk, Ian Lindeman, Pieter Okkerse, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
British Journal of Clinical Pharmacology|March 27, 2016
Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciaticaPieter Okkerse, Justin L Hay, Eve Versage, et al.
British Journal of Anaesthesia|March 28, 2019
Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA<sub>A</sub> partial agonist, in humansGuido van Amerongen, Pieter S Siebenga, Rachel Gurrell, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2016
Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjectsMicha Mm Wilhelmus, Justin L Hay, Rob Gja Zuiker, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 3, 2026
Ultrafast Track Pathway After Low-Risk Cardiac Surgery Enables Intensive Care Unit Stepdown Within 6 Hours: A Feasible Model for Anesthesia-Led RecoveryAlex G M Cotovanu, Remco R Berendsen, Eveline L A van Dorp, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|May 12, 2016
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task BatteryJustin L Hay, Pieter Okkerse, Guido van Amerongen, et al.
British Journal of Clinical Pharmacology|December 18, 2016
Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic propertiesPieter Okkerse, Justin L Hay, Elske Sitsen, et al.
Anesthesiology|September 16, 2014
Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteersMargot Roozekrans, Rutger van der Schrier, Pieter Okkerse, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy SubjectsMichiel J van Esdonk, Ian Lindeman, Pieter Okkerse, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
British Journal of Clinical Pharmacology|March 27, 2016
Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciaticaPieter Okkerse, Justin L Hay, Eve Versage, et al.
British Journal of Anaesthesia|March 28, 2019
Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA<sub>A</sub> partial agonist, in humansGuido van Amerongen, Pieter S Siebenga, Rachel Gurrell, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2016
Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjectsMicha Mm Wilhelmus, Justin L Hay, Rob Gja Zuiker, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 3, 2026
Ultrafast Track Pathway After Low-Risk Cardiac Surgery Enables Intensive Care Unit Stepdown Within 6 Hours: A Feasible Model for Anesthesia-Led RecoveryAlex G M Cotovanu, Remco R Berendsen, Eveline L A van Dorp, et al.
Pageof 1